您的位置: 首页 > 农业专利 > 详情页

PI3K protein kinase inhibitors, particularly delta and / or gamma inhibitors
专利权人:
Rhizen Pharmaceuticals S.A.
发明人:
BHAVAR, Prashant Kashinath,VAKKALANKA, Swaroop Kumar Venkata Satya,BABU, Govindarajulu
申请号:
ES14752404
公开号:
ES2672018T3
申请日:
2014.07.01
申请国别(地区):
ES
年份:
2018
代理人:
摘要:
A compound of formula (II): ** Formula ** or a tautomer thereof, N-oxide thereof, pharmaceutically acceptable ester thereof, or pharmaceutically acceptable salt thereof, wherein each occurrence of R1 is independently H, alkyl substituted or unsubstituted, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, or halogen; X is CH or N; each occurrence of R is independently H, substituted or unsubstituted alkyl, or halogen; Ra is substituted or unsubstituted alkyl; Rb is independently selected from H and substituted or unsubstituted alkyl; Rc is H, substituted or unsubstituted alkyl, -NH2 or halogen; each occurrence of n is independently selected from 0, 1, 2, 3, and 4; and Cy is selected from ** Formula ** where R2 and R3 are independently selected from H, halogen, hydroxyl, substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, CN, -NH-SO2-R '-NO2, -NH2, -NH-C (O) -R ', -C (O) -NH-R', -SO2-R 'and -SO2NR'R'; R 'is selected from H, hydroxy, halogen, carboxyl, cyano, nitro, oxo (>; = O), thio (>; = S), substituted or unsubstituted alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyl, alkynyl substituted or unsubstituted, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenylalkyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted, substituted or unsubstituted aryl, substituted or substituted arylalkyl unsubstituted, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heteroarylalkyl; and R4 is H or substituted or unsubstituted alkyl.U compuesto de fórmula (II):**Fórmula** o un tautómero del mismo, N-óxido del mismo, éster farmacéuticamente aceptable del mismo, o sal farmacéuticamente aceptable del mismo, en la que cada aparición de R1 es independientemente H, alquilo sustituido o sin sustituir, alquenilo sustituido o sin sustituir, alquinilo
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充